Cargando…
BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil
BACKGROUND: This study aims to investigate the combination effect of a novel sirtuin inhibitor (BZD9L1) with 5-fluorouracil (5-FU) and to determine its molecular mechanism of action in colorectal cancer (CRC). METHODS: BZD9L1 and 5-FU either as single treatment or in combination were tested against...
Autores principales: | Tan, Yi Jer, Lee, Yeuan Ting, Petersen, Sven H., Kaur, Gurjeet, Kono, Koji, Tan, Soo Choon, Majid, Amin M. S. Abdul, Oon, Chern Ein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767736/ https://www.ncbi.nlm.nih.gov/pubmed/31632470 http://dx.doi.org/10.1177/1758835919878977 |
Ejemplares similares
-
BZD9L1 Differentially Regulates Sirtuins in Liver-Derived Cells by Inducing Reactive Oxygen Species
por: Lee, Yeuan Ting, et al.
Publicado: (2023) -
BZD9L1 benzimidazole analogue hampers colorectal tumor progression by impeding angiogenesis
por: Oon, Chern Ein, et al.
Publicado: (2023) -
Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine
por: Lee, Yeuan Ting, et al.
Publicado: (2023) -
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
por: Lee, Yeuan Ting, et al.
Publicado: (2020) -
Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model
por: Yehya, Ashwaq Hamid Salem, et al.
Publicado: (2022)